Equalum Ltd. is a technology company that specializes in a data-beaming platform designed for real-time data ingestion and processing, focusing on Big Data solutions for enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, Equalum enables organizations to transport data from a variety of sources, including message queues, sensors, files, applications, and databases, to cloud services and analytics platforms. The company's platform is recognized for its ease of use, featuring a drag-and-drop interface and robust data replication and streaming ETL tools, such as Spark and Kafka. Equalum's technology supports real-time data pipelines, facilitating data warehouse modernization, real-time analytics, and applications in artificial intelligence and machine learning. Trusted by Fortune 500 and mid-sized enterprises, Equalum aims to simplify data integration processes with a zero-coding approach and minimal maintenance requirements.
Xage Security
Series B in 2022
Xage Security, Inc. is a cybersecurity company specializing in blockchain-protected security solutions for industrial Internet of Things (IoT) applications. Founded in 2016 and headquartered in Palo Alto, California, Xage develops a comprehensive security platform that includes products such as the Xage Gateway, which connects to various IIoT edge devices to provide authentication and enforcement; the Xage Broker, which synchronizes credentials and policies; and the Xage Security Cloud for configuration and monitoring. The company's offerings also encompass features like tamper-proofing, edge authentication, role-based access control, and device lifecycle management. Xage serves a diverse range of industries, including energy, transportation, manufacturing, and healthcare, with a focus on delivering zero trust access and protection to safeguard against advanced threats.
Minerva Networks
Secondary Market in 2017
Minerva Networks is a provider of carrier-grade IPTV service management software, specializing in video networking and management solutions. The company offers an open platform that enables telecommunications, cable, satellite operators, internet service providers, and broadcasters to deliver a comprehensive array of video services over broadband Internet Protocol (IP) networks. Their platform supports features such as live television, video-on-demand, and electronic program guides, along with blended internet and television capabilities. Additionally, Minerva Networks provides a suite of professional services to assist in the deployment of end-to-end video networking solutions, ensuring that subscribers can access an enhanced entertainment experience on any device and across various networks at any time.
Direct Flow Medical
Series C in 2016
Direct Flow Medical is a medical device company specializing in the development of innovative transcatheter aortic valve replacement systems aimed at treating heart valve diseases. The company's primary focus is on creating a percutaneous aortic tissue valve prosthesis, which offers patients suffering from cardiac valve insufficiency a safe and effective treatment option. With approximately 1.2 million individuals over the age of 65 affected by calcified aortic valves, and only about 150,000 receiving surgical intervention annually, Direct Flow Medical addresses a significant gap in patient care. Their technology allows heart surgeons to conduct repeated assessments of hemodynamic performance prior to final implantation, thereby enhancing patient outcomes and minimizing complications associated with invasive surgeries.
Actelis Networks
Venture Round in 2016
Actelis Networks, Inc. specializes in high-performance broadband solutions over copper, enabling the delivery of Ethernet and broadband access services. Founded in 1998 and headquartered in Fremont, California, the company offers a range of products, including aggregation switches, Ethernet access devices, and various broadband amplifiers. Its solutions cater to service operators and government customers, addressing needs in residential broadband, business Ethernet, small cell and Wi-Fi backhaul, as well as intelligent traffic systems and municipal networks. Actelis Networks effectively transforms copper infrastructure into a strategic asset, facilitating reliable and cost-effective connectivity for Internet of Things (IoT) projects across diverse environments such as cities, campuses, and military bases. The company emphasizes security in its networking solutions, ensuring protection for critical IoT data through advanced coding and encryption technologies. Actelis distributes its products via a network of resellers and maintains research and development facilities in Tel Aviv, alongside regional sales offices globally.
InnFocus is a biomaterials company, develops and provides products in ophthalmology. The company's product portfolio includes an intraocular lens for microincision surgery and an implantable device for glaucoma. The company was incorporated in 2003 and is based in Miami, Florida.
eBags.com
Venture Round in 2015
eBags, Inc. is a prominent online retailer specializing in a diverse range of bags and travel accessories catering to various lifestyles. Founded in 1999 and based in Greenwood Village, Colorado, eBags offers an extensive selection of products, including luggage, travel bags, handbags, backpacks, and fashion accessories such as cosmetic bags and wallets. The company features products for all demographics, including men, women, and children, and provides items designed for travel, fitness, and outdoor activities. eBags partners with well-known brands like Samsonite, JanSport, and The North Face, ensuring a broad selection of premium products. Committed to exceptional customer service, eBags offers personalized assistance and real-time order tracking to enhance the shopping experience. As of 2017, eBags operates as a subsidiary of Samsonite LLC.
OraMetrix
Debt Financing in 2015
OraMetrix, Inc. provides 3-D technology solutions for facilitating and improving the quality of orthodontic care. It offers an orthodontic treatment system that allows the use of precision digital tools throughout the diagnosis, treatment planning and monitoring, and arch wire customization processes of the orthodontic treatment. OraMetrix, Inc. was formerly known as Orthotel, Inc. The company was founded in 1998 and is based in Richardson, Texas with an additional office in Berlin, Germany.
Kona Medical
Debt Financing in 2015
Kona Medical, Inc. is a medical technology company that specializes in developing a non-invasive ultrasound-based therapy system aimed at treating hypertension and related disorders. Established in 2009 by Dr. Michael Gertner, the company focuses on addressing the challenges posed by drug-resistant hypertension through innovative approaches, particularly renal artery denervation. Its flagship product, Surround Sound, employs ultrasound imaging to precisely guide the delivery of focused ultrasound energy for renal denervation, offering a less invasive alternative to traditional treatments. Based in Issaquah, Washington, Kona Medical integrates Dr. Gertner's inventions with assets from Therus Corporation, enhancing its capabilities in therapeutic focused ultrasound.
Cianna Medical
Venture Round in 2015
Cianna Medical, Inc. is a women's health company focused on developing innovative medical technologies for the treatment of early-stage breast cancer. Headquartered in Aliso Viejo, California, the company was incorporated in 2007 and is dedicated to enhancing breast conservation therapy (BCT) options for women diagnosed with breast cancer. Cianna Medical's notable products include SAVI SCOUT, a wire-free radar localization solution that assists in accurately locating breast tumors, and SAVI Brachy, which delivers targeted radiation to minimize damage to surrounding healthy tissue. Additionally, the company provides a surgical guidance system that utilizes real-time audible and visual indicators to improve precision during lumpectomy and excisional biopsy procedures. Through its advancements, Cianna Medical aims to increase access to effective treatment options for women facing breast cancer. As of November 2018, Cianna Medical operates as a subsidiary of Merit Medical Systems, Inc.
VisionSense
Debt Financing in 2015
VisionSense is a company focused on developing innovative visualization solutions for minimally invasive surgery (MIS). By utilizing advanced sensor technology and proprietary software, VisionSense provides a system that offers natural stereoscopic sight, delivering depth perception and 3D-HD resolution images. This technology allows for maneuvering flexibility through the smallest access points, addressing the limitations of traditional 2D (monocular) imaging that often hinders a surgeon's perspective. With enhanced tissue understanding and improved hand-eye coordination, surgeons are empowered to perform more complex procedures with greater confidence, particularly when using advanced articulating surgical tools.
Gilt Groupe
Series F in 2015
Gilt Groupe is an online retail platform based in New York City that specializes in luxury goods. It offers a wide selection of merchandise, including fashion for men, women, and children, as well as home decor and unique experiences in select cities. The company provides clothing, shoes, and accessories for men, and a diverse range of products for women, including handbags, jewelry, watches, health and beauty items, and maternity wear. For children, Gilt Groupe features clothing, toys, books, and home essentials, while its home category includes furniture, bedding, decor, and kitchen products. Founded in 2007 by Alexandra Wilkis Wilson, Alexis Maybank, and others, Gilt Groupe operates as a subsidiary of Hudson's Bay Company since February 2016, focusing on delivering an accessible and streamlined shopping experience for luxury lifestyle brands.
OrSense Ltd. is a medical device company based in Petah-Tikva, Israel, founded in 1996. The company specializes in developing and marketing non-invasive monitoring technologies for measuring various blood parameters. Its flagship product, the NBM 200 system, enables continuous monitoring of blood hemoglobin levels, oxygen saturation, and pulse rate without the need for invasive procedures. The NBM 200MP further enhances this capability by measuring multiple blood parameters, including hematocrit and low perfusion oximetry. OrSense's technology, based on proprietary Occlusion Spectroscopy, addresses challenges such as poor peripheral perfusion and motion-induced noise, making it suitable for use in hospitals, outpatient sites, and emergency services. The company’s non-invasive hemoglobin and hematocrit monitor has received CE approval and has been tested on over 4,000 patients across multiple clinical sites in the U.S. and Europe.
MedVantx
Debt Financing in 2014
MedVantx, headquartered in San Diego, California, is a consumer medication management and delivery company that aims to reduce healthcare costs and improve access to information for patients, healthcare providers, payors, employers, and manufacturers. The company operates a state-of-the-art mail order pharmacy located in Sioux Falls, South Dakota, which is licensed to serve all 50 states. This facility has been upgraded to meet over 200 current Good Manufacturing Practice (cGMP) quality standards and is equipped to handle pharmaceuticals requiring Cold Chain processing. MedVantx has developed a direct-to-patient platform that connects pharmaceutical manufacturers with patients, streamlining delivery processes and enhancing user experience while minimizing costs. In 2009, MedVantx was recognized by Inc. Magazine as the fastest growing privately held healthcare company in the United States.
VisionCare Ophthalmic Technologies
Venture Round in 2014
VisionCare Ophthalmic Technologies, Inc., established in 1997 and headquartered in Saratoga, California, is a specialty medical device company dedicated to improving vision for individuals with untreatable retinal disorders. The company focuses on the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices. Its flagship product, the Implantable Miniature Telescope (IMT), is an FDA-approved device designed to enhance vision in patients with end-stage age-related macular degeneration (AMD). The IMT is integral to the CentraSight treatment program, which guides patients through diagnosis, surgical evaluation, and postoperative care. VisionCare's mission is to restore visual functionality and improve quality of life for individuals with untreatable retinal disorders, primarily focusing on End-Stage AMD, the leading cause of blindness in older Americans.
VaxInnate
Venture Round in 2014
VaxInnate is a vaccine company founded in 2002 and headquartered in Cranbury, New Jersey, that specializes in developing vaccines for various infectious diseases, including flu, malaria, dengue, papillomavirus, and respiratory syncytial virus. The company utilizes a unique technology that involves genetically fusing vaccine antigens to the bacterial protein flagellin, enhancing the immunogenicity and efficacy of its vaccines. This innovative approach allows for quicker treatment initiation, increasing the likelihood of successful patient outcomes. VaxInnate operates within the healthcare, health diagnostics, and biotechnology sectors, focusing on advancing vaccine development to address significant global health challenges.
InnoPath
Debt Financing in 2014
InnoPath is a developer of software focused on mobile device management services, catering primarily to wireless operators and mobile device manufacturers. The company's technology facilitates the remote connection, configuration, troubleshooting, and security of end-user mobile devices. Through its solutions, such as mobileUpdate and activeCare2, InnoPath enables operators and manufacturers to perform over-the-air updates, diagnostics, and repairs. This approach not only aids in avoiding device recalls and returns but also reduces the frequency of support calls and enhances the first call resolution for issues pertaining to Android and iOS devices. Ultimately, InnoPath's technology contributes to increased subscriber satisfaction by ensuring efficient support and care for mobile devices in a constantly connected environment.
Vidyo, Inc. is a prominent developer of high-definition video conferencing software, aiming to enhance visual communication across various sectors. Established in 2005 and headquartered in Hackensack, New Jersey, Vidyo offers a comprehensive suite of products, including the VidyoDesktop application for desktop users, VidyoMobile for smartphones and tablets, and VidyoRoom solutions for in-office conferencing. These products facilitate seamless participation in video meetings from diverse environments, whether in an office or remote location, and are supported by browser extension capabilities for ease of access. The company caters to multiple industries such as healthcare, education, government, and enterprise, emphasizing customized applications for specific organizational needs. Known for its innovative technology, Vidyo has a global presence with offices in several countries, serving a diverse array of clients, including notable organizations in various fields. As a recognized leader in the video conferencing space, Vidyo aims to make video communication more accessible and effective for users worldwide.
Circadence
Debt Financing in 2014
Circadence Corporation is a leading developer of products and solutions designed to optimize network infrastructure and enhance cybersecurity readiness. Founded in 1993 and based in Boulder, Colorado, with additional offices in Tupelo, Mississippi, McLean, Virginia, and Littleton, Colorado, the company offers a range of products, including the MVO 1200 WAN Optimization suite, which improves application performance and user experience. Circadence also provides a suite of MVO appliances for managing remote network connections and various cybersecurity training solutions, including cyber range design and development, and a cybersecurity awareness learning platform known as inCyt. Catering to enterprises, healthcare, oil and gas sectors, small and medium businesses, public sector organizations, and government entities, Circadence emphasizes innovative and immersive training experiences that adapt to evolving cyber threats. The company is recognized as a Microsoft Gold Partner, reflecting its commitment to delivering cutting-edge cybersecurity solutions.
MBlox
Debt Financing in 2014
MBlox, established in 1999, is a pioneering global mobile messaging company. It maintains over 100 direct carrier relationships and is renowned for its expertise in SMS services. The company's cloud-based platform processes 7 billion mobile messages annually for more than 4,000 clients, ranging from start-ups to multinational corporations. MBlox offers 24/7 email support and customizable support packages to cater to diverse business needs. Its services span various sectors, including financial services, government, transportation, retail, and advertising.
Mitralign
Venture Round in 2014
Mitralign is a privately held medical device company based in a suburb of Boston, Massachusetts. It specializes in developing catheter-based technologies for the percutaneous treatment of functional mitral regurgitation, a global and life-threatening cardiac condition. The company's innovative Mitralign system mimics surgical annuloplasty by delivering a series of implants directly into the mitral annulus via a catheter, reducing its size and improving valve function. Mitralign is backed by top-tier venture capitalists and has strategic investments from major cardiovascular device companies.
Arcadia Biosciences
Series D in 2014
Arcadia Biosciences, Inc. is an agricultural technology company based in Davis, California, focusing on the development of crop productivity traits primarily in hemp, wheat, and soybean. Established in 2002, the company employs advanced screening, breeding, and biotechnology techniques to create products that enhance farm economics and improve the value of crops as food ingredients, health and wellness products, and for industrial applications. Its product lineup includes GoodHemp, a range of non-GMO hemp seed varieties aimed at genetic improvement; GoodWheat, which transforms wheat into a functional food; and a drought and herbicide-tolerant soybean trait known as HB4. Additionally, Arcadia Biosciences produces plant-based food and beverage products, including high-fiber pasta and coconut water, thereby catering to consumer demands while promoting environmental sustainability. The company operates in diverse markets, including the United States, Canada, Africa, and India, and collaborates with several industry partners to advance its initiatives.
OrSense Ltd. is a medical device company based in Petah-Tikva, Israel, founded in 1996. The company specializes in developing and marketing non-invasive monitoring technologies for measuring various blood parameters. Its flagship product, the NBM 200 system, enables continuous monitoring of blood hemoglobin levels, oxygen saturation, and pulse rate without the need for invasive procedures. The NBM 200MP further enhances this capability by measuring multiple blood parameters, including hematocrit and low perfusion oximetry. OrSense's technology, based on proprietary Occlusion Spectroscopy, addresses challenges such as poor peripheral perfusion and motion-induced noise, making it suitable for use in hospitals, outpatient sites, and emergency services. The company’s non-invasive hemoglobin and hematocrit monitor has received CE approval and has been tested on over 4,000 patients across multiple clinical sites in the U.S. and Europe.
Transonic Combustion
Debt Financing in 2014
Transonic Combustion, founded in 2006 and headquartered in Camarillo, California, specializes in advanced fuel injection systems designed to enhance the efficiency of modern automotive engines. The company's TSCi™ fuel delivery technology is tailored for global automotive manufacturers, aiming to improve fuel efficiency and performance in various engine platforms. Transonic Combustion is backed by notable venture capital firms, including Venrock, Khosla Ventures, Rustic Canyon, and Saints Capital, indicating strong investor confidence in its innovative approach to fuel technology.
VisionSense
Series E in 2014
VisionSense is a company focused on developing innovative visualization solutions for minimally invasive surgery (MIS). By utilizing advanced sensor technology and proprietary software, VisionSense provides a system that offers natural stereoscopic sight, delivering depth perception and 3D-HD resolution images. This technology allows for maneuvering flexibility through the smallest access points, addressing the limitations of traditional 2D (monocular) imaging that often hinders a surgeon's perspective. With enhanced tissue understanding and improved hand-eye coordination, surgeons are empowered to perform more complex procedures with greater confidence, particularly when using advanced articulating surgical tools.
Actelis Networks
Debt Financing in 2014
Actelis Networks, Inc. specializes in high-performance broadband solutions over copper, enabling the delivery of Ethernet and broadband access services. Founded in 1998 and headquartered in Fremont, California, the company offers a range of products, including aggregation switches, Ethernet access devices, and various broadband amplifiers. Its solutions cater to service operators and government customers, addressing needs in residential broadband, business Ethernet, small cell and Wi-Fi backhaul, as well as intelligent traffic systems and municipal networks. Actelis Networks effectively transforms copper infrastructure into a strategic asset, facilitating reliable and cost-effective connectivity for Internet of Things (IoT) projects across diverse environments such as cities, campuses, and military bases. The company emphasizes security in its networking solutions, ensuring protection for critical IoT data through advanced coding and encryption technologies. Actelis distributes its products via a network of resellers and maintains research and development facilities in Tel Aviv, alongside regional sales offices globally.
Xtime
Venture Round in 2014
Xtime is a prominent provider of hosted Customer Relationship Management (CRM) and scheduling software specifically designed for automotive service departments in North America. The company serves over 3,000 dealerships and manages more than 1 million customer appointments monthly. Xtime is recognized as the exclusive or preferred software provider for several leading global automotive manufacturers, including Lexus, Toyota, BMW, and Mercedes-Benz. Additionally, it is a trusted partner for many significant dealership groups, such as AutoNation and Group 1 Automotive. Based in Redwood Shores, California, Xtime's integrated software solutions enhance marketing, sales, service, and operations workflows, ensuring that automotive service departments can meet the evolving demands of consumers effectively.
NComputing
Debt Financing in 2014
NComputing, Inc. is a provider of client virtualization solutions based in Santa Clara, California, founded in 2003. The company specializes in enabling users to access personalized desktops, applications, and data from any device and location, leveraging its advanced technology platform. This platform incorporates UXP transmission protocols, a virtualization server, application awareness, and thin client devices, allowing NComputing to deliver low-cost computing solutions tailored for various sectors, including education, healthcare, finance, manufacturing, and government. With approximately 4 million seats installed across more than 60,000 customers, NComputing focuses on simplicity, performance, and value, serving both larger enterprises and small to medium-sized businesses.
OrSense
Debt Financing in 2014
OrSense Ltd. is a medical device company based in Petah-Tikva, Israel, founded in 1996. The company specializes in developing and marketing non-invasive monitoring technologies for measuring various blood parameters. Its flagship product, the NBM 200 system, enables continuous monitoring of blood hemoglobin levels, oxygen saturation, and pulse rate without the need for invasive procedures. The NBM 200MP further enhances this capability by measuring multiple blood parameters, including hematocrit and low perfusion oximetry. OrSense's technology, based on proprietary Occlusion Spectroscopy, addresses challenges such as poor peripheral perfusion and motion-induced noise, making it suitable for use in hospitals, outpatient sites, and emergency services. The company’s non-invasive hemoglobin and hematocrit monitor has received CE approval and has been tested on over 4,000 patients across multiple clinical sites in the U.S. and Europe.
BioSET
Debt Financing in 2014
BioSET, Inc., founded in 2001 and based in Rockville, Maryland, specializes in the research and development of synthetic bioactive peptides aimed at enhancing bone and soft tissue repair. The company creates proprietary therapeutic peptides utilized as medical devices in orthobiologics applications. Its notable product, Amplex, is an implantable device that combines a peptide with a synthetic ceramic scaffold, designed for use in spinal fusion surgeries and other orthopedic procedures. Additionally, BioSET develops products for sports medicine and creates peptide signaling molecules along with various scaffold biomaterials for applications in trauma, fracture repair, and soft tissue treatments. As of February 2015, BioSET operates as a subsidiary of Ferring Pharmaceuticals Inc.
Vidyo, Inc. is a prominent developer of high-definition video conferencing software, aiming to enhance visual communication across various sectors. Established in 2005 and headquartered in Hackensack, New Jersey, Vidyo offers a comprehensive suite of products, including the VidyoDesktop application for desktop users, VidyoMobile for smartphones and tablets, and VidyoRoom solutions for in-office conferencing. These products facilitate seamless participation in video meetings from diverse environments, whether in an office or remote location, and are supported by browser extension capabilities for ease of access. The company caters to multiple industries such as healthcare, education, government, and enterprise, emphasizing customized applications for specific organizational needs. Known for its innovative technology, Vidyo has a global presence with offices in several countries, serving a diverse array of clients, including notable organizations in various fields. As a recognized leader in the video conferencing space, Vidyo aims to make video communication more accessible and effective for users worldwide.
Art.com is an online platform specializing in the sale of wall art and decorative items, founded in 1998 and headquartered in San Bruno, California. The company offers a diverse range of products, including high-quality wall art, limited-edition prints, hand-painted originals, and home accessories. It serves a wide array of customers, including retail partners, museums, hotels, and interior designers, providing them with innovative art solutions to enhance their spaces. Art.com aims to facilitate exploration and expression through art, catering to individuals seeking to personalize their environments.
Xtime
Venture Round in 2012
Xtime is a prominent provider of hosted Customer Relationship Management (CRM) and scheduling software specifically designed for automotive service departments in North America. The company serves over 3,000 dealerships and manages more than 1 million customer appointments monthly. Xtime is recognized as the exclusive or preferred software provider for several leading global automotive manufacturers, including Lexus, Toyota, BMW, and Mercedes-Benz. Additionally, it is a trusted partner for many significant dealership groups, such as AutoNation and Group 1 Automotive. Based in Redwood Shores, California, Xtime's integrated software solutions enhance marketing, sales, service, and operations workflows, ensuring that automotive service departments can meet the evolving demands of consumers effectively.
Transonic Combustion
Series D in 2012
Transonic Combustion, founded in 2006 and headquartered in Camarillo, California, specializes in advanced fuel injection systems designed to enhance the efficiency of modern automotive engines. The company's TSCi™ fuel delivery technology is tailored for global automotive manufacturers, aiming to improve fuel efficiency and performance in various engine platforms. Transonic Combustion is backed by notable venture capital firms, including Venrock, Khosla Ventures, Rustic Canyon, and Saints Capital, indicating strong investor confidence in its innovative approach to fuel technology.
Mitralign
Series D in 2012
Mitralign is a privately held medical device company based in a suburb of Boston, Massachusetts. It specializes in developing catheter-based technologies for the percutaneous treatment of functional mitral regurgitation, a global and life-threatening cardiac condition. The company's innovative Mitralign system mimics surgical annuloplasty by delivering a series of implants directly into the mitral annulus via a catheter, reducing its size and improving valve function. Mitralign is backed by top-tier venture capitalists and has strategic investments from major cardiovascular device companies.
Cellomics Technology
Seed Round in 2012
Cellomics Technology LLC is a biotechnology company based in the Biotech Corridor of the Nation’s Capital, specializing in gene targeting in mammalian cells. The company develops and offers tools for genetic engineering, focusing on somatic and stem cells, while providing professional services tailored to specific research requirements. With an emphasis on leveraging its expertise in lentiviral vector production, Cellomics Technology aims to provide a broad array of pre-made lentiviral vectors to support academic, biotechnology, and pharmaceutical research initiatives. The company is committed to helping its clients accelerate their gene targeting projects through innovative products and customized services.
Solace Therapeutics
Venture Round in 2012
Solace Therapeutics, Inc. is a medical device company based in Framingham, Massachusetts, that specializes in developing non-surgical, office-based treatments for common bladder disorders, including stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction, and lower urinary tract symptoms (LUTS). The company’s flagship product, the Vesair Bladder Control System, is a lightweight device designed to float within the urinary bladder, effectively addressing involuntary urinary leakage without the need for anesthesia or surgical intervention. Solace Therapeutics aims to enhance patients' quality of life by offering a treatment option that minimizes the side effects often associated with traditional drug and surgical therapies, allowing for a reversible and less intrusive approach to bladder health.
Radius Health
Private Equity Round in 2011
Radius Health, Inc. is a biopharmaceutical company specializing in the development and commercialization of endocrine therapeutics, particularly targeting osteoporosis and oncology. The company markets TYMLOS, an anabolic agent aimed at treating postmenopausal women with osteoporosis. In addition to TYMLOS, Radius is advancing several clinical candidates, including abaloparatide-SC for men with osteoporosis, a transdermal patch for postmenopausal women, Elacestrant for hormone receptor-positive breast cancer, and RAD140 for metastatic breast cancer. Founded in 2003 and headquartered in Waltham, Massachusetts, Radius collaborates with various organizations, including 3M Company and Ipsen Pharma, to enhance its research and development efforts. The company is committed to addressing unmet medical needs in bone health and women's health, with a long-term vision of expanding its therapeutic focus.
CircuLite
Series D in 2011
CircuLite is a cardiovascular device company focused on transforming the treatment of heart failure through the development of minimally-invasive micro-pumps designed for long-term partial circulatory support. Its proprietary micro-pump platform allows for the creation of compact devices that can be implanted in a superficial pocket, similar to a pacemaker, utilizing endovascular or minimally-invasive surgical techniques. By supplementing a patient's natural heart function, CircuLite aims to provide a proactive and lower-risk treatment option, thereby enhancing the quality of life for millions of individuals suffering from chronic heart failure. The company’s flagship product, the Synergy Pocket Circulatory Assist Device, is designed to rest a failing heart while supporting its natural pumping capacity.
Radius Health
Series C in 2011
Radius Health, Inc. is a biopharmaceutical company specializing in the development and commercialization of endocrine therapeutics, particularly targeting osteoporosis and oncology. The company markets TYMLOS, an anabolic agent aimed at treating postmenopausal women with osteoporosis. In addition to TYMLOS, Radius is advancing several clinical candidates, including abaloparatide-SC for men with osteoporosis, a transdermal patch for postmenopausal women, Elacestrant for hormone receptor-positive breast cancer, and RAD140 for metastatic breast cancer. Founded in 2003 and headquartered in Waltham, Massachusetts, Radius collaborates with various organizations, including 3M Company and Ipsen Pharma, to enhance its research and development efforts. The company is committed to addressing unmet medical needs in bone health and women's health, with a long-term vision of expanding its therapeutic focus.
Cianna Medical
Series B in 2011
Cianna Medical, Inc. is a women's health company focused on developing innovative medical technologies for the treatment of early-stage breast cancer. Headquartered in Aliso Viejo, California, the company was incorporated in 2007 and is dedicated to enhancing breast conservation therapy (BCT) options for women diagnosed with breast cancer. Cianna Medical's notable products include SAVI SCOUT, a wire-free radar localization solution that assists in accurately locating breast tumors, and SAVI Brachy, which delivers targeted radiation to minimize damage to surrounding healthy tissue. Additionally, the company provides a surgical guidance system that utilizes real-time audible and visual indicators to improve precision during lumpectomy and excisional biopsy procedures. Through its advancements, Cianna Medical aims to increase access to effective treatment options for women facing breast cancer. As of November 2018, Cianna Medical operates as a subsidiary of Merit Medical Systems, Inc.
AngioScore
Venture Round in 2011
AngioScore Inc. is a medical device company that specializes in the development, manufacturing, and marketing of innovative angioplasty catheters aimed at treating cardiovascular and vascular diseases. The company's flagship product, the AngioSculpt Scoring Balloon Catheter, is designed for use in both coronary and peripheral interventional markets. This device addresses the limitations of traditional angioplasty balloon catheters by integrating a semi-compliant balloon with a unique nitinol scoring element, enhancing the effectiveness of vascular interventions. AngioScore's focus on advancing endovascular therapy tools positions it as a key player in the medical device industry dedicated to improving patient outcomes in vascular treatments.
Capella
Venture Round in 2011
Capella specializes in wavelength selective switch (WSS) technology, primarily for applications in reconfigurable optical add/drop multiplexers (ROADM) and optical cross connects (OXC). The company's advanced intelligent subsystems are designed to enhance wavelength management, offering dynamic and remote reconfigurability. Capella's products integrate optical channel monitoring, which is crucial for the performance and efficiency of next-generation ROADM systems. By focusing on these technologies, Capella positions itself as a leader in the optical networking industry, providing essential solutions that streamline operations for its users.
VisionCare Ophthalmic Technologies
Series E in 2011
VisionCare Ophthalmic Technologies, Inc., established in 1997 and headquartered in Saratoga, California, is a specialty medical device company dedicated to improving vision for individuals with untreatable retinal disorders. The company focuses on the research, development, manufacture, and marketing of proprietary implantable ophthalmic devices. Its flagship product, the Implantable Miniature Telescope (IMT), is an FDA-approved device designed to enhance vision in patients with end-stage age-related macular degeneration (AMD). The IMT is integral to the CentraSight treatment program, which guides patients through diagnosis, surgical evaluation, and postoperative care. VisionCare's mission is to restore visual functionality and improve quality of life for individuals with untreatable retinal disorders, primarily focusing on End-Stage AMD, the leading cause of blindness in older Americans.
Estech, founded in 1996 by Arthur and Raymond Bertolero, is a privately held medical device manufacturing and distribution company based in San Ramon, California. The company specializes in developing and marketing medical devices and disposables for cardiac surgery, with a focus on least invasive products. Estech's global distribution network and commitment to innovation have attracted top professionals in the medical device industry. The company's success is attributed to the extensive experience and dedication of its team, which has enabled it to thrive in the competitive medical device market.
Laureate Pharma
Debt Financing in 2010
Laureate Pharma, Inc., a contract manufacturing organization, provides development and cGMP manufacturing services. It focuses on mammalian cell based monoclonal antibody and recombinant protein production for clinical and commercial supply. The company's biopharmaceutical production/biotherapeutics production services include cGMP production and purification, protein modification and conjugation, formulation and aseptic filling into vials and finishing, upstream and downstream process development, Cell Line Optimization, medium optimization studies and adapting cells to protein-free medium, pilot-scale bioreactor runs, and product formulation development. Its services also comprise transfection, cloning, and selection to create new cell lines; analytical method transfer, development, and qualification; and preclinical production, monoclonal antibody production, and clinical trials manufacturing. Laureate Pharma supports the development and commercialization of biopharmaceutical, drug, and diagnostic products for pharmaceutical, diagnostic, and biotech companies. The company was formerly known as Bard Biopharma L.P. and changed its name to Laureate Pharma, Inc. in 2002. The company is headquartered in Princeton, New Jersey.
Angi
Venture Round in 2010
Angi is a company that connects consumers with quality home service professionals across various sectors, including repair, remodeling, cleaning, and landscaping. It offers a platform where users can find vetted professionals, read verified reviews, and obtain reasonable prices for a wide range of home projects and services. Angi operates through multiple brands, including Angi, HomeAdvisor, and Handy, and has three main segments: Ads and Leads, which generates the bulk of its revenue, Services, and International operations in Europe and Canada. The majority of Angi's revenue is derived from the United States, reflecting its strong presence in the home services market.
Incline Therapeutics
Series A in 2010
Incline Therapeutics is a privately-held specialty pharmaceutical company that concentrates on developing innovative pain management solutions for hospital settings. The company's primary focus is on IONSYS, a fentanyl iontophoretic transdermal system designed as a patient-controlled analgesia option for adult inpatients who require opioid pain relief following surgery. This system offers a compact and disposable approach, utilizing a needleless design for the short-term management of postoperative pain. Incline Therapeutics is backed by prominent life science venture capital firms and is guided by an experienced management team with considerable expertise in the pharmaceutical and medical device industries.
KXEN, Inc., founded in 1998 and headquartered in San Francisco, California, is a company specializing in data mining automation. It offers business analytics software tailored for customer lifecycle analytics, supply chain analytics, and business intelligence to support corporate decision-making. KXEN's products include various software packages for functions such as classification, regression, clustering, and segmentation, along with single-purpose analysis applications for forecasting, market basket analysis, prediction, and more. The company also provides technical support, education services including training courses and certification programs, and consulting services. KXEN serves clients primarily in the financial services, telecommunications, and retail industries, operating through systems integrators, software vendors, and original equipment manufacturers both domestically and internationally.
MicroCHIPS
Venture Round in 2010
MicroCHIPS Biotech, Inc. specializes in developing a microchip-based implant designed for drug delivery applications across various therapeutic areas, including osteoporosis, diabetes, multiple sclerosis, women’s contraception, and pain management. This innovative implant can store and release precise doses of medication over extended periods, offering an alternative to traditional therapies that rely on frequent injections. The implant is surgically placed under the skin during a minimally invasive procedure and can be wirelessly activated or deactivated by healthcare providers or patients. Additionally, the device allows for real-time adjustments to the drug dosage and frequency, catering to the specific needs of each patient. Established in 1999 and headquartered in Lexington, Massachusetts, MicroCHIPS operates as a subsidiary of Daré Bioscience, Inc.
MediaKind
Debt Financing in 2009
MediaKind, headquartered in Frisco, Texas, specializes in media technology. It develops and provides solutions such as media platforms, video decoding, processing, and storage, along with management and control software. The company offers two key platforms: Mediaroom, an IPTV platform, and MediaFirst, a cloud-based TV platform. Additionally, it provides solutions in video processing, stream management, and advertising. MediaKind serves global telecommunications, cable, satellite, and media companies, enabling them to deliver engaging video content across various devices and networks.
Coapt Systems
Debt Financing in 2009
Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.
Actelis Networks
Venture Round in 2009
Actelis Networks, Inc. specializes in high-performance broadband solutions over copper, enabling the delivery of Ethernet and broadband access services. Founded in 1998 and headquartered in Fremont, California, the company offers a range of products, including aggregation switches, Ethernet access devices, and various broadband amplifiers. Its solutions cater to service operators and government customers, addressing needs in residential broadband, business Ethernet, small cell and Wi-Fi backhaul, as well as intelligent traffic systems and municipal networks. Actelis Networks effectively transforms copper infrastructure into a strategic asset, facilitating reliable and cost-effective connectivity for Internet of Things (IoT) projects across diverse environments such as cities, campuses, and military bases. The company emphasizes security in its networking solutions, ensuring protection for critical IoT data through advanced coding and encryption technologies. Actelis distributes its products via a network of resellers and maintains research and development facilities in Tel Aviv, alongside regional sales offices globally.
Estech
Venture Round in 2009
Estech, founded in 1996 by Arthur and Raymond Bertolero, is a privately held medical device manufacturing and distribution company based in San Ramon, California. The company specializes in developing and marketing medical devices and disposables for cardiac surgery, with a focus on least invasive products. Estech's global distribution network and commitment to innovation have attracted top professionals in the medical device industry. The company's success is attributed to the extensive experience and dedication of its team, which has enabled it to thrive in the competitive medical device market.
Estech
Venture Round in 2008
Estech, founded in 1996 by Arthur and Raymond Bertolero, is a privately held medical device manufacturing and distribution company based in San Ramon, California. The company specializes in developing and marketing medical devices and disposables for cardiac surgery, with a focus on least invasive products. Estech's global distribution network and commitment to innovation have attracted top professionals in the medical device industry. The company's success is attributed to the extensive experience and dedication of its team, which has enabled it to thrive in the competitive medical device market.
Broncus Medical
Series G in 2008
Broncus Medical is a medical technology company specializing in the development of minimally-invasive devices for treating lung diseases, including emphysema and lung cancer. Based in Mountain View, California, with an international presence in Nyon, Switzerland, Broncus is focused on addressing significant unmet medical needs in interventional pulmonology. The company is exploring its Exhale product line, which features a patented treatment method known as Airway Bypass, aimed at providing a minimally-invasive solution for patients suffering from homogeneous emphysema. Broncus is currently conducting the pivotal EASE Trial, enrolling patients worldwide to evaluate the efficacy of this treatment in severe cases of the disease. Additionally, Broncus offers a range of innovative products designed to enhance diagnostic and therapeutic outcomes in lung care, including the Archimedes System, LungPoint, and InterVapor System.
Arcadia Biosciences
Private Equity Round in 2008
Arcadia Biosciences, Inc. is an agricultural technology company based in Davis, California, focusing on the development of crop productivity traits primarily in hemp, wheat, and soybean. Established in 2002, the company employs advanced screening, breeding, and biotechnology techniques to create products that enhance farm economics and improve the value of crops as food ingredients, health and wellness products, and for industrial applications. Its product lineup includes GoodHemp, a range of non-GMO hemp seed varieties aimed at genetic improvement; GoodWheat, which transforms wheat into a functional food; and a drought and herbicide-tolerant soybean trait known as HB4. Additionally, Arcadia Biosciences produces plant-based food and beverage products, including high-fiber pasta and coconut water, thereby catering to consumer demands while promoting environmental sustainability. The company operates in diverse markets, including the United States, Canada, Africa, and India, and collaborates with several industry partners to advance its initiatives.
MediaKind
Venture Round in 2008
MediaKind, headquartered in Frisco, Texas, specializes in media technology. It develops and provides solutions such as media platforms, video decoding, processing, and storage, along with management and control software. The company offers two key platforms: Mediaroom, an IPTV platform, and MediaFirst, a cloud-based TV platform. Additionally, it provides solutions in video processing, stream management, and advertising. MediaKind serves global telecommunications, cable, satellite, and media companies, enabling them to deliver engaging video content across various devices and networks.
Alliance Consulting Group
Acquisition in 2008
Alliance Consulting Group is a Boston-based strategy consulting firm founded in 1986. The company specializes in providing a range of consulting services for commercial clients, including business process redesign, customer needs and segmentation analysis, innovation and new product development, market and competitive analysis, profit improvement, sales effectiveness, strategic planning, and sustainability strategies. Alliance Consulting Group is committed to delivering exceptional value through a unique approach to strategy development, characterized by rigor and creativity. Their focus is on helping clients grow their businesses by offering tailored solutions that meet specific organizational needs, while fostering an engaging and dynamic environment for their staff.
LifeMasters Supported SelfCare
Venture Round in 2008
LifeMasters Supported SelfCare is a prominent disease management company that specializes in creating health partnerships among individuals, their physicians, and payors. The company offers interactive disease management services, focusing on relief programs for various chronic conditions, including diabetes, congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, hypertension, asthma, cancer, metabolic syndrome, and musculoskeletal pain. LifeMasters aims to support individuals in managing their health while providing decision support for healthcare providers and reducing costs for payors. Through its comprehensive programs, the company fosters improved health outcomes and promotes effective self-care practices.
Zonare Medical Systems
Series G in 2007
Zonare Medical Systems, Inc. specializes in the development, manufacturing, and commercialization of compact ultrasound systems designed for diagnostic imaging across various clinical applications. The company's flagship product, the z.one ultrasound system, utilizes its proprietary Zone Sonography technology, which enhances data acquisition and image formation, allowing customers to maintain the system while adding new clinical applications and advanced imaging capabilities. Zonare Medical Systems sells its products through a direct sales force in the United States and a combination of distributors and direct sales representatives in approximately 40 international markets. Founded in 1999 and headquartered in Mountain View, California, the company was previously known as NovaSonics, Inc.
Blip is an online media platform that offers users access to a variety of video clips and programs focused on media and entertainment. The platform features content across multiple categories, including general entertainment, comedy, music, drama, television, food, and video games. It organizes its offerings into segments such as editors' picks, current trends, and new episodes. Additionally, Blip provides producers with tools to host, distribute, and monetize their web series. Founded in 2005 by Charles Hope and Jared Klett, Blip is headquartered in New York City.
SideStep is a metasearch engine designed to assist travelers by searching over 200 travel websites to find the best deals on flights, hotels, and other travel-related services. The company generates revenue through advertising and referral fees. SideStep has expanded its offerings by acquiring TripUp, a social network focused on travel, and TravelPost.com, a hotel ratings site, aiming to become a leading source of online travel information. Additionally, SideStep has developed Facebook applications such as Trips, which offers trip planning services with over 150,000 users, and Extended Info, allowing users to customize their Facebook profiles. The company was acquired by Kayak in December 2007 for approximately $180 million.
Forte Design Systems
Series D in 2006
Forte Design Systems, Inc. is a software provider specializing in semiconductor design solutions. Founded in 2001 and headquartered in San Jose, California, with additional offices in various U.S. states and internationally in France and Japan, the company offers Cynthesizer, a silicon-proven behavioral synthesis technology that generates production-quality RTL. This innovative technology enables design teams to develop complex electronic systems from algorithmic designs using ASICs, FPGAs, and SoCs, effectively reducing design and verification time. Forte's products cater to a range of industries, including consumer electronics, digital media, wireless communications, and security. The company maintains a direct sales presence in North America, Europe, and Japan, and has established value-added reseller partnerships in Korea.
Seven Networks
Venture Round in 2006
SEVEN Networks, Inc. is a software company that specializes in device-centric mobile traffic management and analytics for wireless carriers globally. Founded in 2000 and headquartered in San Carlos, California, SEVEN Networks offers a range of products, including its Open Channel software line, which enhances mobile traffic visibility and optimization while improving end-user experiences. The company's mobile applications facilitate social messaging for consumers and provide carriers with tools for effective communication across various platforms. Additionally, SEVEN’s Push Technology and Notifications reduce network traffic and increase user engagement with mobile services. The company also provides technical support and professional services, including solution integration and device management. With a robust portfolio of over three hundred patents and extensive industry recognition, SEVEN Networks is noted for its innovations in mobile traffic management and analytics, making it a leader in optimizing wireless infrastructure.
PatientKeeper
Series E in 2006
PatientKeeper is a company that specializes in developing EHR optimization software aimed at enhancing healthcare delivery. Its solutions are designed to streamline clinical and revenue cycle workflows for healthcare providers, care teams, billers, and coders, ultimately improving patient care and operational efficiency. PatientKeeper serves as a system of engagement that complements existing EHR systems, enabling providers to easily access and manage patient information across various devices, including smartphones, tablets, and PCs. The company’s applications allow physicians to efficiently handle patient data, view clinical results, enter diagnoses and billing information, dictate notes, and write prescriptions, thereby facilitating a more intuitive and effective approach to patient management.
Novera Optics
Venture Round in 2006
Novera Optics specializes in the development of optical access solutions aimed at enhancing fiber-optic technology for last-mile networks. The company provides Passive Optical Network (PON) solutions that support fiber-to-the-building and fiber-to-the-curb applications, as well as services for multi-dwelling and multi-tenant units. Novera Optics also offers Wavelength Division Multiplexed-Passive Optical Networks (WDM-PON), which serve as an access and transport platform that facilitates the delivery of voice, data, video, and wireless services. By extending high-speed carrier Ethernet services from optical core networks to customer premises, Novera Optics enables equipment vendors and service providers to effectively address various market needs with a streamlined product offering.
Vua Ke Sat
Series E in 2005
NextWeb is a wireless Internet service provider, providing high-speed service to more than 1000 enterprise customers in Northern and Southern California. NextWeb's service is available in over 50,000 business locations in more than 60 cities. Typically installed in just three to seven days, NextWeb's service is 30 percent faster than a T1 at approximately half the cost, easily scaling to six times the speed of a T1.
MetaTV was founded in 1999 to define technology and services which would forever change the way people look at television.